Federal Register / Vol. 74, No. 13 / Thursday, January 22, 2009 / Notices 4039 

additional three-year period. Responses 

will be submitted electronically using a 

web-based survey instrument. Minor 

changes to the instrument are proposed 

to address compliance with 

recommendations made in the updated 

PHS clinical practice guideline issued 

in May of 2008, such as coverage for 

combination therapies, smokeless 

tobacco use, and states’ familiarity with 

and use of the 2000 PHS guideline. The 

minor changes are not expected to affect 

the overall burden estimate. To 

minimize burden, each respondent will 

only be asked to record changes that 

occurred since the time of the previous 

submission. As in previous years, each 

respondent will also attach a copy of the 

state’s Medicaid coverage plan to their 

completed survey, in order to assist the 

research team with the interpretation of 

responses. 

The information to be collected will 

allow CDC to continue monitoring 

compliance with the most recent PHS 

recommendations and the progress of 

State Medicaid Programs toward the 

2010 National Health Objectives and 

Healthy People 2010 goals. 

There are no costs to respondents 

except the time to complete the survey. 

The total estimated burden hours are 26. 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondents Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

State Medicaid Programs ............................................................................................................ 51 1 30/60 

Dated: January 13, 2009. 

Maryam I. Daneshvar, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E9–1227 Filed 1–21–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

The National Institute for Occupational 

Safety and Health (NIOSH) of the 

Centers for Disease Control and 

Prevention (CDC) Announces an 

Evaluation of Downdraft Vented Nail 

Salon Tables (VNTs) 

Authority: 29 U.S.C. Sections 651 et seq. 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC), 

Department of Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Division of Applied 

Research and Technology (DART), 

NIOSH, is conducting an evaluation of 

downdraft vented salon nail tables 

(VNTs). This notice invites developers, 

manufacturers, and vendors of VNTs to 

submit new, unused, downdraft VNTs 

for evaluation of operational 

characteristics and effectiveness in 

reducing levels of a source point tracer 

gas at standard distances from the vent. 

A 6-month supply of manufacturer 

recommended filters is to be submitted 

to NIOSH at the address below, together 

with the VNT. 

Evaluation parameters for the VNTs 

will include, but are not limited to: 

Airflow and capture characteristics, 

noise level, ergonomic features, and 

filter life. Manufacturers, vendors, and 

developers who wish to submit VNTs 

with filters for evaluation are invited to 

respond to this announcement. A report 

on each VNT submitted for evaluation, 

including feedback on the evaluation 

parameters and staff recommendations, 

will be sent to the submitter. Results of 

the evaluation will potentially be used 

to develop educational materials for nail 

technicians and may also be 

disseminated through reports, 

publications, or presentations. NIOSH 

does not intend to identify 

manufacturers in its publications but 

testing information referencing 

particular manufacturers would be 

releasable if requested under the 

Freedom of Information Act (FOIA). 

DATES: Written letter of interest must be 

received within 90 calendar days of 

publication in the Federal Register. The 

deadline for receipt of VNT and filter 

submissions is June 30, 2009. 

Evaluations will begin subject to the 

dates VNT and filter submissions are 

received. The VNTs will be retained for 

up to 10 months while being evaluated, 

after which they will be returned. 

ADDRESSES: Manufacturers, vendors, 

and developers who wish to submit 

VNTs with filters for evaluation are 

invited to respond to this 

announcement by sending a written 

letter of interest to NIOSH/DART, 

Robert A. Taft Laboratories, 4676 

Columbia Parkway, Mailstop C–23, 

Cincinnati, Ohio 45226, Attention: 

Susan Reutman, e-mail address: 

SReutman@cdc.gov. 

SUPPLEMENTARY INFORMATION: Responses 

shall include: A description of the VNT 

including the manufacturer, schedule of 

availability of the VNT and filters for 

evaluation, and a statement of the terms 

under which the VNT will be made 

available for evaluation. Shipping and 

handling costs (including insurance) to 

ship the VNTs to NIOSH and for NIOSH 

to return the VNTs to the submitter will 

be the responsibility of the submitter. 

NIOSH reserves the right to decide 

which VNT submissions will be 

evaluated based on compliance with the 

specifications described above. NIOSH 

also reserves the right not to proceed in 

this manner. 

Note: As a government entity, we cannot 

endorse any specific product directly, 

indirectly, or by implication. NIOSH will not 

be responsible for any costs related to usage, 

wear and tear or accidental damage to the 

VNT during transport or while the VNT is at 

NIOSH. 

Contact Person for Technical 

Information: Susan Reutman, Ph.D., 

telephone (513) 533–8286, or e-mail 

SReutman@cdc.gov. 

Dated: January 2, 2009. 

James D. Seligman, 

Chief Information Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. E9–1193 Filed 1–21–09; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2008–D–0264] 

Compliance Policy Guide Sec. 

540.370—Fish and Fishery Products— 

Decomposition; Availability 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing the 


rmajette on PRODPC74 with NOTICES
4040 Federal Register / Vol. 74, No. 13 / Thursday, January 22, 2009 / Notices 

availability of Compliance Policy Guide 

Sec. 540.370—Fish and Fishery 

Products—Decomposition (the CPG). 

The CPG provides guidance for FDA 

staff on decomposition in fish and 

fishery products. 

DATES: Submit written or electronic 

comments on the CPG at any time. 

ADDRESSES: Submit written comments 

on the CPG to the Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, rm. 

1061, Rockville, MD 20852. Submit 

electronic comments to http:// 

www.regulations.gov. Submit written 

requests for single copies of the CPG to 

the Division of Compliance Policy 

(HFC–230), Office of Enforcement, Food 

and Drug Administration, 5600 Fishers 

Lane, Rockville, MD 20857. Send two 

self-addressed adhesive labels to assist 

that office in processing your request, or 

fax your request to 240–632–6861. See 

the SUPPLEMENTARY INFORMATION section 

for electronic access to the CPG. 

FOR FURTHER INFORMATION CONTACT: 

Robert D. Samuels, Center for Food 

Safety and Applied Nutrition (HFS– 

325), Food and Drug Administration, 

100 Paint Branch Pkwy., College Park, 

MD 20740, 301–436–2300. 

SUPPLEMENTARY INFORMATION: 

I. Background 

In the Federal Register of July 18, 

2008 (73 FR 41361), FDA announced the 

availability of draft CPG Sec. 540.370— 

Fish and Fishery Products— 

Decomposition and gave interested 

parties an opportunity to submit 

comments. The agency received no 

comments on the draft CPG but on its 

own initiative made a few editorial 

changes for clarification purposes. The 

CPG provides guidance for FDA staff on 

decomposition in fish and fishery 

products. The CPG also contains 

information that may be useful to the 

regulated industry and to the public. 

FDA is issuing this CPG as a level 1 

guidance consistent with FDA’s good 

guidance practices regulation (21 CFR 

10.115). The CPG represents the 

agency’s current thinking on FDA’s 

direct reference enforcement criteria 

related to decomposition in fish and 

fishery products. It does not create or 

confer any rights for or on any person 

and does not operate to bind FDA or the 

public. An alternative approach may be 

used if such approach satisfies the 

requirements of the applicable statutes 

and regulations. 

II. Comments 

Interested persons may submit to the 

Division of Dockets Management (see 

ADDRESSES) written or electronic 

comments regarding this document. 

Submit a single copy of electronic 

comments or two paper copies of any 

mailed comments, except that 

individuals may submit one paper copy. 

Comments are to be identified with the 

docket number found in brackets in the 

heading of this document. The CPG and 

received comments may be seen in the 

Division of Dockets Management 

between 9 a.m. and 4 p.m., Monday 

through Friday. 

Please note that on January 15, 2008, 

the FDA Division of Dockets 

Management Web site transitioned to 

the Federal Dockets Management 

System (FDMS). FDMS is a 

Government-wide, electronic docket 

management system. Electronic 

comments or submissions will be 

accepted by FDA only through FDMS at 

http://www.regulations.gov. 

III. Electronic Access 

Persons with access to the Internet 

may obtain the CPG at http://www.fda.

gov/ora/compliance_ref/cpg/

default.htm. 

Dated: January 12, 2009. 

Michael A. Chappell, 

Acting Associate Commissioner for 

Regulatory Affairs. 

[FR Doc. E9–1142 Filed 1–21–09; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Leadership Education in 

Neurodevelopmental and Other 

Related Disabilities MCH Training 

Program 

AGENCY: Health Resources and Services 

Administration (HRSA), HHS. 

ACTION: Notice of Class Deviation from 

Project/Budget Period Funding Policies. 

SUMMARY: HRSA will provide 2 

additional years of support in the 

absence of competition for one cohort of 

grants under the Leadership Education 

in Neurodevelopmental and Other 

Related Disabilities (LEND) MCH 

Training Program. HRSA will extend the 

project period to June 30, 2011, for the 

cohort of the LEND program expected to 

compete in fiscal year (FY) 2009, which 

would correspond to the sunset of the 

Combating Autism Act. Currently, there 

are 34 LEND grants split into two 

cohorts (17 each) with different end 

dates; one group is scheduled to 

compete in FY 2009 (Cohort A), and the 

other in FY 2011 (Cohort B). HRSA will 

non-competitively extend with funds 

the 5-year project periods for those 

LEND grantees ending on June 30, 2009, 

for 2 additional budget periods at the 

same level of support for the same scope 

of activities which they received in FY 

2008. 

SUPPLEMENTARY INFORMATION: 

Intended Recipients of the Award 

Seventeen programs in the LEND 

cohort are expected to compete in FY 

2009. These programs presently have 

active LEND grants: University of Iowa, 

Johns Hopkins University, University of 

Missouri, University of Nebraska, 

Dartmouth Hitchcock Medical Center, 

Albert Einstein College of Medicine, 

Children’s Hospital of Pittsburgh, 

University of South Dakota, University 

of Vermont, Virginia Commonwealth 

University, West Virginia University, 

University of Massachusetts Medical 

School, Ohio State University, 

Vanderbilt University, Children’s 

Research Institute, Indiana University, 

University of Oklahoma. 

Amount of Individual Supplemental 

Awards: Note: These funding levels are 

expected to continue in FYs 2009 and 

2010. 

Grantee FY 2008 

award 

University of Iowa ..................... $491,265 

Johns Hopkins University ......... 884,277 

University of Missouri ............... 393,012 

University of Nebraska ............. 412,663 

Dartmouth Hitchcock Medical 

Center ................................... 451,964 

Albert Einstein College of Medicine ........................................ 491,265 

Children’s Hospital of Pittsburgh ..................................... 393,012 

University of South Dakota ....... 432,313 

University of Vermont ............... 451,964 

Virginia Commonwealth University ......................................... 451,964 

West Virginia University ........... 439,825 

University of Massachusetts 

Medical School ...................... 604,256 

Ohio State University ................ 393,011 

Vanderbilt University ................. 393,012 

Children’s Research Institute ... 393,012 

Indiana University ..................... 481,440 

University of Oklahoma ............ 442,139 

Current Project Periods: 7/1/04 

through 6/30/09. 

Period of Supplemental Funding: 

7/1/09 through 6/30/11. 

Authority: Combating Autism Act of 2006, 

Public Law No. 109–416, § 399BB(e)(1)(A), 

120 Stat 2821, 2826 (2006). 

CFDA Number: 93.110. 

FOR FURTHER INFORMATION CONTACT: 

Laura Kavanagh; Branch Chief, MCH 

Training Program, Division of Research, 

Training and Education; Maternal and 

Child Health Bureau; (301) 443–2254. 


rmajette on PRODPC74 with NOTICES